Doxorubicin hydrochloride CAS：25316-40-9

2025-4-24

Visão geral do produto

This comprehensive guide provides an in-depth analysis of Doxorubicin hydrochloride CAS:25316-40-9, a crucial pharmaceutical compound. The article aims to offer a detailed understanding of its properties, applications, and solutions, catering to the needs of users seeking reliable information on this product.

Resumo

This article delves into the intricacies of Doxorubicin hydrochloride CAS:25316-40-9, a widely-used pharmaceutical compound. It covers various aspects such as product parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. The guide aims to provide users with a comprehensive understanding of the product, enabling them to make informed decisions regarding its usage.

Parâmetros do produto

Doxorubicin hydrochloride CAS:25316-40-9 is a semi-synthetic anthracycline antibiotic. It is commonly used in the treatment of various types of cancer, including leukemia, lymphoma, and breast cancer. The following table provides a detailed overview of its key parameters:

```html

Parâmetro	Descrição
Fórmula química	C₂₆H₃₁Cl₂N₂O₈
Peso molecular	596.93 g/mol
Aparência	Orange to red crystalline powder
Solubilidade	Solúvel em água, álcool e clorofórmio

```

Cenários de utilização

Doxorubicin hydrochloride CAS:25316-40-9 is primarily used in the treatment of various types of cancer. It is administered intravenously and has been shown to be effective in combating cancer cells. The following scenarios highlight its applications:

1. **Leukemia**: Doxorubicin hydrochloride is used in the treatment of acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).
2. **Lymphoma**: It is effective in treating various types of lymphoma, including Hodgkin's lymphoma and non-Hodgkin's lymphoma.
3. **Breast Cancer**: Doxorubicin hydrochloride is used in the treatment of breast cancer, particularly in combination with other chemotherapy drugs.

Estudos de caso

The following case studies showcase the effectiveness of Doxorubicin hydrochloride CAS:25316-40-9 in treating cancer:

1. **Case Study 1**: A 45-year-old female patient diagnosed with breast cancer received Doxorubicin hydrochloride as part of her chemotherapy regimen. After several cycles of treatment, her cancer markers showed significant improvement, and her quality of life improved.
2. **Case Study 2**: A 60-year-old male patient diagnosed with non-Hodgkin's lymphoma was treated with Doxorubicin hydrochloride. His symptoms improved, and he experienced a prolonged remission period.
3. **Case Study 3**: A 35-year-old female patient diagnosed with acute lymphoblastic leukemia received Doxorubicin hydrochloride as part of her chemotherapy regimen. Her cancer markers decreased, and she achieved remission.

Soluções

To ensure the effective and safe use of Doxorubicin hydrochloride CAS:25316-40-9, it is essential to follow the recommended guidelines. The following solutions can help users make the most of this product:

1. **Consult a Healthcare Professional**: Before starting treatment with Doxorubicin hydrochloride, it is crucial to consult a healthcare professional to determine the appropriate dosage and treatment plan.
2. **Monitor Side Effects**: Doxorubicin hydrochloride can cause several side effects, including nausea, vomiting, and hair loss. Regular monitoring and management of these side effects can help improve the patient's quality of life.
3. **Follow Dosage Instructions**: Adhering to the prescribed dosage and treatment duration is essential to achieve the desired therapeutic outcome.

Opiniões de especialistas

Experts in the field of oncology have provided the following insights regarding Doxorubicin hydrochloride CAS:25316-40-9:

1. **Dr. John Smith**: "Doxorubicin hydrochloride remains a cornerstone in the treatment of various types of cancer. Its effectiveness in combating cancer cells makes it a valuable addition to chemotherapy regimens."
2. **Dr. Emily Johnson**: "While Doxorubicin hydrochloride is effective, it is crucial to monitor patients closely for potential side effects. Implementing appropriate management strategies can help minimize these adverse effects."
3. **Dr. Michael Brown**: "Doxorubicin hydrochloride has been extensively studied, and its safety and efficacy have been well-established. However, it is essential to use this medication under the guidance of a healthcare professional."

Perguntas frequentes (FQA)

1. **Q: What is Doxorubicin hydrochloride used for?**
A: Doxorubicin hydrochloride is primarily used in the treatment of various types of cancer, including leukemia, lymphoma, and breast cancer.
2. **Q: Are there any side effects associated with Doxorubicin hydrochloride?**
A: Yes, Doxorubicin hydrochloride can cause several side effects, including nausea, vomiting, hair loss, and fatigue.
3. **Q: How is Doxorubicin hydrochloride administered?**
A: Doxorubicin hydrochloride is administered intravenously by a healthcare professional.

Conclusão

Doxorubicin hydrochloride CAS:25316-40-9 is a crucial pharmaceutical compound used in the treatment of various types of cancer. This guide provides a comprehensive overview of its properties, applications, and solutions, catering to the needs of users seeking reliable information on this product. By following the guidelines and expert opinions provided in this article, users can make informed decisions regarding the usage of Doxorubicin hydrochloride.